MedPath

Adaptive Research and Western Radiation Oncology Partner to Expand Cancer Trial Access in San Francisco Bay Area

10 months ago2 min read

Key Insights

  • Adaptive Research and Western Radiation Oncology (WRO) have partnered to broaden access to innovative cancer treatment trials for patients in the San Francisco Bay Area.

  • WRO will gain comprehensive research administration through Adaptive Research's network, including project management, regulatory compliance, and technological solutions.

  • The collaboration aims to democratize clinical trials by enabling community physicians to participate in research, accelerating the development of life-altering cancer treatments.

Adaptive Research and Western Radiation Oncology (WRO) have announced a partnership aimed at expanding access to innovative cancer treatment trials for patients in the San Francisco Bay Area. This collaboration seeks to bring emerging therapies to community practices, enhancing cancer research in real-world settings.

Partnership Details

As part of the Adaptive Research network, Western Radiation Oncology will receive comprehensive research administration support. This includes dedicated project management, regulatory compliance, financial administration, research staffing, and technological solutions for patient recruitment and data management. This support aims to mitigate logistical barriers that often prevent community practices from participating in clinical research.

Strategic Importance

Deepak Behera, MD, CEO of Adaptive Research, stated, "By bringing clinical trials directly to community practices, we can provide patients with access to emerging therapies while advancing cancer research in real-world settings." This partnership reflects Adaptive Research’s mission to democratize clinical trials, ensuring broader patient access to potentially life-altering cancer treatments.
Dr. Ankit Agarwal, MD, MBA, Medical Director at Western Radiation Oncology, expressed enthusiasm about the collaboration, stating, "By actively participating in clinical trials, our patients not only have the opportunity to receive innovative investigational therapies but also contribute to the development of life-saving advancements in cancer care."

Adaptive Research's Role

Adaptive Research, established in 2020, operates a community-based clinical trials network, connecting trial sponsors with community physicians across multiple therapeutic areas. The company provides the infrastructure, expertise, and administrative support needed for community physicians to participate in clinical research while focusing on patient care. This centralized platform aims to make clinical trials more accessible to diverse patient populations.

Western Radiation Oncology's Expertise

Western Radiation Oncology specializes in radiation therapy treatments across multiple cancer types, combining clinical expertise with advanced radiation therapy technology to deliver comprehensive cancer care. Through this partnership, WRO furthers its commitment to providing patients with access to the latest treatment options through clinical trials.
Subscribe Icon

Stay Updated with Our Daily Newsletter

Get the latest pharmaceutical insights, research highlights, and industry updates delivered to your inbox every day.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.